Experts still won’t agree on whether to carry out randomized trial to put an end to this discussion, but it seems clear that balloon expandable TAVR is valid only for certain anatomies. TAVR in real world bicuspid valve populations is associated with similar outcomes at 30 days and one year when compared against cohorts<a href="https://solaci.org/en/2019/03/22/acc-2019-tavr-in-bicuspids-is-safe-and-feasible-in-real-world-patients/" title="Read more" >...</a>
Courtesy of Dr. Carlos Fava. Mitral regurgitation is the most frequent type of valve disease, accounting for >6% of patients over 65 years old. Surgery is currently the strategy of choice, but percutaneous treatment is a valid alternative. The long-term progress of symptomatic patients at high surgical risk who do not meet the formal indications for<a href="https://solaci.org/en/2019/02/01/good-outcomes-for-mitraclip-off-label/" title="Read more" >...</a>
Transcatheter tricuspid valve replacement is feasible with different devices, with a reasonable procedural success rate, and is associated with low peri-procedural mortality and significant clinical improvement. Mid-term survival was favorable in this high-risk population. Greater leaflet coaptation depth was associated with reduced procedural success, which, unsurprisingly, turned out to be an independent predictor of mortality.<a href="https://solaci.org/en/2019/01/07/more-evidence-for-the-forgotten-valve-results-from-the-trivalve-registry/" title="Read more" >...</a>
The aim of this study was to assess the use of measuring left atrial pressure to complement transesophageal echocardiography and doppler imaging. Procedure efficacy is measured in the cath lab by echocardiography. However, these measurements are operator dependent and might be influenced by left ventricular function and changes in left atrial compliance. The study<a href="https://solaci.org/en/2019/01/04/continuous-monitoring-of-left-atrial-pressure-during-mitraclip-regardless-echocardiography/" title="Read more" >...</a>
All over the world, functional lesion measurement remains underutilized due to the need for a hyperemic stimulus (which may be avoided with instantaneous wave-free ratio [iFR]) and, above all, the invasiveness of guidewire placement (crossing the intended lesion) for the measurement. These guidewires have improved a lot, but they still lack the navigating capacity of<a href="https://solaci.org/en/2018/10/08/tct-2018-fast-ffr-angiography-derived-ffr-without-hyperemic-stimulus-or-invasive-guidewire-placement/" title="Read more" >...</a>
Prosthesis-patient mismatch (i.e. a difference between the size of the implanted prosthetic valve and the patient body size) in patients who undergo surgery is associated with worse outcomes. This may also apply to percutaneous prostheses, although that has not been well-studied yet. This work, presented at TCT 2018 and published simultaneously in JACC, analyzes this problem<a href="https://solaci.org/en/2018/10/08/tct-2018-mismatch-after-tavr-according-to-the-tvt-registry/" title="Read more" >...</a>
With a mean follow up of 15 years, and some patients that survived over 20 years, this study shows that more than 75% of patients with rheumatic mitral stenosis show sustained results with balloon valvuloplasty. Predictors of this excellent long-term outcome are many, but they are determined mainly by age, prior symptoms and valve area<a href="https://solaci.org/en/2018/08/23/balloon-mitral-valvuloplasty-at-very-long-term/" title="Read more" >...</a>
Current models are not reliable when it comes to predicting events after carotid revascularization in acute patients. Peri-procedural events seem to be particularly hard to predict. The development of models that can be externally validated is essential for the decision-making process in patients with high event rates, both during the procedure or while the case<a href="https://solaci.org/en/2018/08/22/how-to-predict-events-in-order-to-decide-whether-to-revascularize-symptomatic-carotid-artery-stenosis/" title="Read more" >...</a>
See the list of winners for all contests carried out as part of the last SOLACI-SOCIME 2018 Congress. The names were announced on Friday, August 3rd, at the Congress closing ceremony. SOLACI-SOCIME 2018 Congress Best Abstract Award: Winners: Dr. Botelho Carlos, Dr. Padilla Lucio, Dr. Harada Ribeiro Marcelo, Dr Araya Mario, Dr. Ybarra Luis<a href="https://solaci.org/en/2018/08/15/solaci-socime-2018-congress-here-are-the-winners/" title="Read more" >...</a>
Endovascular therapy is now considered as the standard of care for acute ischemic stroke caused by large vessel occlusion. The time between symptoms onset and reperfusion emerges as the most determinant factor for good clinical outcomes, much more strongly than even in acute myocardial infarction. The saying “time is brain” is even more relevant than<a href="https://solaci.org/en/2018/07/04/endovascular-therapy-in-stroke-much-evidence-and-few-trained-operators/" title="Read more" >...</a>